Torres Robinson

RESULTS CCS uptake remained relatively stable over time, with a mean coverage of 70.9% in Belgium and 73.1% in Switzerland. Educational and income gradients were found in both countries. Concerning CCS overuse, women above screening-eligible age showed consistently high screening rates, but screening within the past year declined significantly in…[Read more]

The combined technique achieved a good scar quality and aesthetic effect on burned hands as well as excellent functional outcome, which resulted in major improvements and an independent life for the patient.

Astragaloside IV (AS-IV) is a natural herb extract and a popular compound used in traditional Chinese medicine because of its effect on…[Read more]

Cross-linked polyethylene (XLPE) has been recognized as an outstanding insulator for high-voltage power cables due to its favorable structural integrity at high temperature, low moisture sensitivity, chemical resistance, and low rates of failure due to aging. However, the roles of by-products and amorphous regions generated during the XLPE…[Read more]

Vergleichbarkeit zur Therapiebeurteilung von soliden Tumoren nach RECIST hergestellt.. · Weitere Studien werden zeigen, welche der Klassifikationen in welchem Studiensetting am besten geeignet ist.. ZITIERWEISE · Skusa C, Weber M, Böttcher S et al. Criteria-Based Imaging and Response Evaluation of Lymphoma 20 Years After Cheson What is New?. Fort…[Read more]

Auricular arteriovenous malformation (AVM) occasionally accompanies macrotia. Here, the authors report a case of AVM with macrotia that was treated with transcatheter arterial embolization, percutaneous sclerotherapy, and subsequent otoplasty following partial resection. A 46-year-old man presented with Schobinger stage III AVM. After…[Read more]

79 . Selleck 3-Aminobenzamide However, we observed no significant difference between 2 treatments in progression-free survival (hazard ratio = 0.96 ). Furthermore, anti-PD1/PD-L1 monotherapy caused less treatment-related adverse events than standard of care.

Anti-PD1/PD-L1 monotherapy could indeed reduce the risk of death in R/M SCCHN…[Read more]